Clinical trials
Phase 3 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,716 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 12 |
| 2002 | 14 |
| 2003 | 25 |
| 2004 | 25 |
| 2005 | 50 |
| 2006 | 93 |
| 2007 | 91 |
| 2008 | 117 |
| 2009 | 111 |
| 2010 | 105 |
| 2011 | 136 |
| 2012 | 147 |
| 2013 | 159 |
| 2014 | 163 |
| 2015 | 192 |
| 2016 | 175 |
| 2017 | 225 |
| 2018 | 296 |
| 2019 | 315 |
| 2020 | 334 |
| 2021 | 451 |
| 2022 | 371 |
| 2023 | 500 |
| 2024 | 515 |
| 2025 | 592 |
| 2026 | 487 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,212 |
| Recruiting | 1,240 |
| Unknown status | 970 |
| Active, not recruiting | 673 |
| Not yet recruiting | 283 |
| Terminated | 260 |
| Withdrawn | 41 |
| Enrolling by invitation | 30 |
| Suspended | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 246 |
| AstraZeneca | 216 |
| Hoffmann-La Roche | 170 |
| Novartis Pharmaceuticals | 157 |
| Fudan University | 131 |
| Eli Lilly and Company | 115 |
| Jiangsu HengRui Medicine Co., Ltd. | 114 |
| Merck Sharp & Dohme LLC | 106 |
| GlaxoSmithKline | 105 |
| Sanofi | 105 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 309 |
| Breast Neoplasms | 259 |
| Diabetes Mellitus, Type 2 | 194 |
| Carcinoma, Hepatocellular | 149 |
| Colorectal Neoplasms | 114 |
| Nasopharyngeal Carcinoma | 113 |
| Stomach Neoplasms | 113 |
| Ischemic Stroke | 100 |
| Obesity | 91 |
| Neoplasm Metastasis | 66 |
Trials
Showing 1 to 25 of 5,716. Each trial links to its page on Pharma Observatory.
5,616 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.